Matthew Turner | Vice President & Head of Patient Affordability Solutions |
Jeff Baker | Chief Financial Officer & Treasurer |
Mark Newcomer | Co-Founder, Vice-Chairman & Chief Executive Officer |
Gary Prestopino | Barrington Research |
Jon Hickman | Ladenburg Thalman |
Hello and welcome to the PaySign Second Quarter 2022 Earnings Conference Call.
As a reminder, this conference is being recorded. This call may include comments that may be deemed to be forward-looking statements under the federal securities laws and the company intends that such forward-looking statements be subject to the safe harbor created thereby. All statements other than statements of fact included on this call are forward-looking statements. Such forward-looking statements include, among others, that our unrestricted cash, anticipated revenues and profits will be sufficient to sustain operations for the next 12 months; that the expected total revenue, gross profit margin, operating expenses, depreciation and amortization, stock-based compensation, adjusted EBITDA, plasma revenues, new plasma center additions, pharma revenues and new pharma co-pay customer additions for 2022 meet our expectations; that the company will continue to post year-over-year improvements; that the company's growth prospects in plasma, pharma and other prepaid business materialize; and that the company will continue to be affected by COVID-19-related labor shortages.